MLH1 is primarily associated with somatic CTNNB1 mutations, while MSH2 is associated with somatic APC mutations, which might explain why MSH2-associated cancers exhibit quick transformation from adenomas to carcinomas with MMR deficiency, while MLH1-associated cancers usually progress without polyp formation. The gene discussed is MSH2; the disease is carcinoma.